BRIEF published on 10/01/2024 at 15:47, 1 year 7 months ago Franchissement de seuil par Mirova dans MEDINCELL Capital Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 10/01/2024 at 15:47, 1 year 7 months ago Threshold crossing by Mirova in MEDINCELL Capital Actions Threshold Crossing Medincell Mirova
PRESS RELEASE published on 10/01/2024 at 15:42, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par Mirova pour le compte de fonds gérés, détenant 7,07% du capital et 5,01% des droits de vote de MEDINCELL Acquisition Franchissement De Seuil AMF Medincell Mirova
BRIEF published on 09/24/2024 at 11:54, 1 year 7 months ago Teva et Medincell Présentent des Résultats Prometteurs sur l'Olanzapine LAI pour la Schizophrénie Schizophrénie Essai Clinique Medincell Teva Olanzapine LAI
BRIEF published on 09/24/2024 at 11:54, 1 year 7 months ago Teva and Medincell Present Promising Results on Olanzapine LAI for Schizophrenia Clinical Trial Schizophrenia Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:53, 1 year 7 months ago Inside Information / Other news releases Teva and Medincell reveal positive efficacy, safety, and tolerability data from Phase 3 study on Olanzapine LAI for schizophrenia treatment, presenting at ECNP 2024 Schizophrenia Treatment Phase 3 Study Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:49, 1 year 7 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Teva présente de nouvelles données sur l'efficacité de l'olanzapine LAI pour la schizophrénie lors de l'ENCP 2024. Collaboration Teva-Medincell pour développement Schizophrénie Efficacité Medincell Teva ENCP 2024
BRIEF published on 09/18/2024 at 10:13, 1 year 7 months ago Mirova franchit le seuil des 5% des droits de vote de MEDINCELL Droits De Vote Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 09/18/2024 at 10:13, 1 year 7 months ago Mirova crosses the threshold of 5% of voting rights in MEDINCELL Voting Rights Actions Threshold Crossing Medincell Mirova
PRESS RELEASE published on 09/18/2024 at 10:08, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par Mirova pour le compte de fonds qu'elle gère concernant MEDINCELL sur Euronext Paris Euronext Paris Franchissement De Seuil Gestion Medincell Mirova
Published on 05/13/2026 at 00:00, 1 hour 25 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 1 hour 50 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 3 hours 30 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 3 hours 43 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 10 hours 55 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 23:47, 1 hour 37 minutes ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 2 hours 59 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 5 hours 3 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 5 hours 50 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 5 hours 50 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 7 hours 10 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 7 hours 10 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 7 hours 15 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 7 hours 15 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 7 hours 35 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
